company background image
300702 logo

Zhejiang Tianyu Pharmaceutical SZSE:300702 Stock Report

Last Price

CN¥17.15

Market Cap

CN¥5.8b

7D

-2.2%

1Y

-27.0%

Updated

20 Nov, 2024

Data

Company Financials +

Zhejiang Tianyu Pharmaceutical Co., Ltd.

SZSE:300702 Stock Report

Market Cap: CN¥5.8b

300702 Stock Overview

Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. More details

300702 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance1/6
Financial Health4/6
Dividends2/6

Zhejiang Tianyu Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Tianyu Pharmaceutical
Historical stock prices
Current Share PriceCN¥17.15
52 Week HighCN¥23.99
52 Week LowCN¥13.16
Beta-0.011
11 Month Change2.63%
3 Month Change14.72%
1 Year Change-27.02%
33 Year Change-64.93%
5 Year Change-34.64%
Change since IPO42.70%

Recent News & Updates

Recent updates

We Think Zhejiang Tianyu Pharmaceutical (SZSE:300702) Is Taking Some Risk With Its Debt

Nov 04
We Think Zhejiang Tianyu Pharmaceutical (SZSE:300702) Is Taking Some Risk With Its Debt

Concerns Surrounding Zhejiang Tianyu Pharmaceutical's (SZSE:300702) Performance

Sep 04
Concerns Surrounding Zhejiang Tianyu Pharmaceutical's (SZSE:300702) Performance

Take Care Before Diving Into The Deep End On Zhejiang Tianyu Pharmaceutical Co., Ltd. (SZSE:300702)

Aug 21
Take Care Before Diving Into The Deep End On Zhejiang Tianyu Pharmaceutical Co., Ltd. (SZSE:300702)

Further Upside For Zhejiang Tianyu Pharmaceutical Co., Ltd. (SZSE:300702) Shares Could Introduce Price Risks After 27% Bounce

May 21
Further Upside For Zhejiang Tianyu Pharmaceutical Co., Ltd. (SZSE:300702) Shares Could Introduce Price Risks After 27% Bounce

Zhejiang Tianyu Pharmaceutical Co., Ltd.'s (SZSE:300702) Revenues Are Not Doing Enough For Some Investors

Mar 17
Zhejiang Tianyu Pharmaceutical Co., Ltd.'s (SZSE:300702) Revenues Are Not Doing Enough For Some Investors

Shareholder Returns

300702CN PharmaceuticalsCN Market
7D-2.2%-5.2%-4.1%
1Y-27.0%-6.7%3.8%

Return vs Industry: 300702 underperformed the CN Pharmaceuticals industry which returned -6.7% over the past year.

Return vs Market: 300702 underperformed the CN Market which returned 3.8% over the past year.

Price Volatility

Is 300702's price volatile compared to industry and market?
300702 volatility
300702 Average Weekly Movement7.8%
Pharmaceuticals Industry Average Movement7.2%
Market Average Movement8.2%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.6%

Stable Share Price: 300702 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300702's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19934,690Yong Jun Tuwww.tianyupharm.com

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series. It provides fine chemicals and CDMO services.

Zhejiang Tianyu Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Tianyu Pharmaceutical's earnings and revenue compare to its market cap?
300702 fundamental statistics
Market capCN¥5.75b
Earnings (TTM)CN¥43.68m
Revenue (TTM)CN¥2.59b

135.0x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300702 income statement (TTM)
RevenueCN¥2.59b
Cost of RevenueCN¥1.75b
Gross ProfitCN¥846.19m
Other ExpensesCN¥802.51m
EarningsCN¥43.68m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.13
Gross Margin32.61%
Net Profit Margin1.68%
Debt/Equity Ratio47.6%

How did 300702 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

40%

Payout Ratio